Comparative Study between Quantitative Digital Image Analysis and Fluorescence In Situ Hybridization of Breast Cancer Equivocal HER2 2+Cases

被引：0
|
作者：
Ayad, E. [1 ]
Mansy, M. [1 ]
Elwi, D. [1 ]
Salem, M. [1 ]
Salama, M. [2 ,3 ]
Kayser, K. [4 ]
机构：
[1] Cairo Univ, Dept Pathol, Fac Med, Cairo, Egypt
[2] Univ Utah, Dept Pathol, Salt Lake City, UT USA
[3] ARUP Reference Lab, Salt Lake City, UT USA
[4] Humboldt Univ, Dept Pathol, D-10099 Berlin, Germany
来源：
ANALYTICAL CELLULAR PATHOLOGY | 2014年 / 2014卷
关键词：
D O I：
10.1155/2014/608254
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Digital imaging correlation of immunohistochemistry and fluorescence in situ hybridization in breast carcinoma cases with HER2 genetic heterogeneity
    Wilcock, Diane M.
    Sirohi, Deepika
    Coleman, Joshua F.
    Gulbahce, H. Evin
    HUMAN PATHOLOGY, 2022, 126 : 129 - 135
  • [22] HER2 Gene Amplification by Fluorescence In Situ Hybridization (FISH) Compared With Immunohistochemistry (IHC) in 122 Equivocal Gastric Cancer Cases
    Liu, Xiaoyan
    Wang, Xiaoling
    Wang, Bo
    Ren, Guoping
    Ding, Wei
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2016, 24 (07) : 459 - 464
  • [23] Automated Image Analysis of HER2 Fluorescence In Situ Hybridization to Refine Definitions of Genetic Heterogeneity in Breast Cancer Tissue
    Radziuviene, Gedmante
    Rasmusson, Allan
    Augulis, Renaldas
    Lesciute-Krilaviciene, Daiva
    Laurinaviciene, Aida
    Clim, Eduard
    Laurinavicius, Arvydas
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [24] Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis
    Lehr, HA
    Jacobs, TW
    Yaziji, H
    Schnitt, SJ
    Gown, AM
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2001, 115 (06) : 814 - 822
  • [25] The Assessment of HER2 Gene Status by Fluorescence In Situ Hybridization in Invasive Breast Carcinomas With Equivocal HER2 Immunostaining: Experience From a Single Institution
    Efared, Boubacar
    Sidibe, Ibrahim S.
    Gamrani, Sana
    El Otmani, Ihsane
    Erregad, Fatimazahra
    Hammas, Nawal
    Bennis, Sanae
    Chbani, Laila
    El Fatemi, Hinde
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2018, 26 (07) : 593 - 599
  • [26] Biological analysis of HER2 equivocal (2+) cases in primary breast cancer.
    Nishimura, Reiki
    Osako, Tomofumi
    Okumura, Yasuhiro
    Nakano, Masahiro
    Fujisue, Mamiko
    Arima, Nobuyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [27] HER2 status in breast carcinomas: comparison between silver in situ hybridization, chromogenic in situ hybridization and fluorescence in situ hybridization
    Ali, S. A. Md
    Nurhayati, H. M.
    Munirah, M. A.
    Reena, M. Z.
    Masir, N.
    Chandramaya, S. F.
    Rohaizak, M.
    Asmiati, A.
    Sharifah, N. A.
    Rafie, M. K.
    EJC SUPPLEMENTS, 2010, 8 (05): : 185 - 185
  • [28] HER-2 gene amplification by fluorescence in situ hybridization (FISH) compared with immunohistochemistry (IHC) in breast cancer: a study of 528 equivocal cases
    Zhang, Han
    Ren, Guoping
    Wang, Xiaoling
    Zhao, Jing
    Yao, Hongtian
    Bai, Yanfeng
    Bo, Wang
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (02) : 743 - 749
  • [29] Fluorescence quantitative image analysis of HER2 evaluation against current clinical HER2 assays in breast cancer testing
    Kornaga, E. N.
    Feng, X.
    Klimowicz, A. C.
    Dean, M. L.
    Guggisberg, N.
    Morris, D. G.
    Magliocco, A. M.
    CANCER RESEARCH, 2016, 76
  • [30] Robust and accurate digital measurement for HER2 amplification in HER2 equivocal breast cancer diagnosis
    Yuefeng Wang
    Julia Y. S. Tsang
    Yongmei Cui
    Ji Cui
    Ying Lin
    Songli Zhao
    Patrick T. W. Law
    Sai Yin Cheung
    Enders K. O. Ng
    Gary M. K. Tse
    Zunfu Ke
    Scientific Reports, 7
12345